Foghorn Therapeutics Inc (FHTX) — Cash Flow Reinvestment Rate
Foghorn Therapeutics Inc (FHTX) has a Cash Flow Reinvestment Rate of 0.59x as of March 2022, reinvesting $159.41 Million (capex $247.00K plus investments $-159.16 Million) from operating cash flow of $271.53 Million. See cash generation quality of Foghorn Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Foghorn Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Foghorn Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Foghorn Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Foghorn Therapeutics Inc (2022–2022)
Year-by-year capital reinvestment analysis for Foghorn Therapeutics Inc. See Foghorn Therapeutics Inc (FHTX) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.26x | $244.32 Million | $193.61 Million | $1.21 Million | — |